Nephronophthisis: Current clinical spectrum and molecular pathogenesis
The FEBS Journal · 04.07.2026
DOI: 10.1111/febs.70646 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The FEBS Journal, online erschienen am 04.07.2026. Verfasst von Ya Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Children and Adolescents' Health and Diseases, Han…. Hauptthemen laut MEDLINE: Kidney Diseases, Cystic, Kidney Failure, Chronic. Die Arbeit nennt 62 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Noncommunicable Chronic Diseases-National Science and Technology Major Project.
Abstract (Originalsprache)
Nephronophthisis (NPH) is a ciliopathy primarily affecting renal tubules and interstitial tissue, ultimately progressing to end‐stage kidney disease (ESKD). The clinical spectrum of NPH is broad and can be classified according to the age at onset into infantile, juvenile, adolescent, and late‐onset forms. Histopathologically, NPH is characterized by corticomedullary cysts, tubular atrophy, interstitial fibrosis, and cystic dilatation of distal tubules. The kidneys may appear normal in early stages but gradually shrink with disease progression. More than 20 causative genes have been identified, with NPHP1 being the most common. These genes encode proteins that localize predominantly to the ciliary transition zone and basal body, where they regulate ciliary structure and signaling. Loss of ciliary function disrupts epithelial polarity, intracellular trafficking, and signal transduction, leading to tubular injury and fibrosis. When extrarenal organs such as the retina, liver, or central nervous system are affected, the condition is defined as nephronophthisis‐related ciliopathies (NPH‐RC). This review summarizes the current understanding of NPH classification, clinical features, and molecular mechanisms. Here, we highlighted recent advances in genetic discoveries, pathogenic signaling pathways, and therapeutic strategies, including gene therapy and targeted molecular interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Children and Adolescents' Health and Diseases, Hangzhou, China.
- Department of Cell Biology, Zhejiang University School of Medicine, Hangzhou, China.
- Kidney Disease Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
ORCID-Profile: Ya Li, Siwei Yang, Xiying Chen, Jianhua Mao, Shanshan Xie
Förderung
- National Natural Science Foundation of China
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
Zitieren
APA
Li, Y., Yang, S., Chen, X., Mao, J., & Xie, S. (2026). Nephronophthisis: Current clinical spectrum and molecular pathogenesis. The FEBS Journal. https://doi.org/10.1111/febs.70646
Vancouver
Li Y, Yang S, Chen X, Mao J, Xie S. Nephronophthisis: Current clinical spectrum and molecular pathogenesis. The FEBS Journal. 2026. doi:10.1111/febs.70646
BibTeX
@article{Li2026,
author = {Li, Ya and Yang, Siwei and Chen, Xiying and Mao, Jianhua and Xie, Shanshan},
title = {Nephronophthisis: Current clinical spectrum and molecular pathogenesis},
journal = {The FEBS Journal},
year = {2026},
doi = {10.1111/febs.70646}
}
EUVIMED